Theriva Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 98.6%.

Top 25 shareholders own 34.99% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.6%	Armistice Capital LLC	225,000	€344.4k	0%	0.01%
13.3%	Heights Capital Management, Inc.	180,000	€275.5k	0%	0.09%
1.77%	MSD Partners, L.P.	23,936	€36.6k	0%	0.02%
0.74%	Steven Shallcross	10,000	€15.3k	0%	no data
0.57%	The Vanguard Group, Inc.	7,779	€11.9k	-13.7%	no data
0.56%	BlackRock, Inc.	7,567	€11.6k	0%	no data
0.42%	Geode Capital Management, LLC	5,646	€8.6k	0%	no data
0.31%	Renaissance Technologies LLC	4,148	€6.3k	51.4%	no data
0.24%	Frank Tufaro	3,225	€4.9k	-0.03%	no data
0.18%	Two Sigma Securities, LLC, Asset Management Arm	2,440	€3.7k	187%	no data
0.14%	State Street Global Advisors, Inc.	1,947	€3.0k	0%	no data
0.078%	Northern Trust Global Investments	1,059	€1.6k	-0.38%	no data
0.033%	Advisor Group Holdings, Inc., Asset Management Arm	440	€673.5	0%	no data
0.03%	William Blair Investment Management, LLC	406	€621.5	0%	no data
0.0019%	Jeffrey Kraws	26	€39.8	0%	no data
0.0015%	Strategic Advisers LLC	20	€30.7	1,900%	no data
0.001%	Iron Horse Wealth Management, LLC	14	€21.3	0%	no data
0.00081%	IFP Advisors, LLC	11	€16.8	0%	no data
0.00037%	Bank of America Corporation, Asset Management Arm	5	€7.7	400%	no data
0.00037%	Tower Research Capital Europe Limited	5	€7.7	0%	no data
0.0003%	Old Point Trust & Financial Services, N.A.	4	€6.2	0%	no data
0.0003%	Wells Fargo & Company, Securities and Brokerage Investments	4	€6.2	0%	no data
0.0003%	Planning Capital Management Corp.	4	€6.2	0%	no data
0.00007%	City National Rochdale, LLC	1	€1.5	0%	no data
0.00007%	UBS Asset Management AG	1	€1.5	0%	no data